What should investors evaluate before backing a start-up in the personalized nutrition market?

Prioritize retention beyond twelve months and margin on refill orders over test-kit volume. Start-ups owning proprietary outcome data attract stronger acquirer interest than formulation-only brands [10]. Read More

How do OTC glucose biosensors compare with genetic tests for personalization?

Biosensors capture day-to-day responses to specific meals, while genetic tests describe fixed predispositions. Glucose data therefore supports frequent regimen changes, whereas genotype results mainly guide one-time baseline choices [13]. Read More

Which regulatory nuance matters most for brands entering the personalized nutrition market in Japan?

Foods with Function Claims allows notified claims backed by systematic reviews rather than pre-approval. After the 2024 red-yeast-rice safety incident, the Consumer Affairs Agency tightened post-market reporting, raising documentation expectations [17]. Read More

How should employers procure personalized nutrition programs for staff?

Employers should negotiate outcome-linked fees tied to HbA1c or weight changes and require that individual data stays outside employer access. This structure keeps vendors in the personalized nutrition market accountable for measurable results [21]. Read More

What integration challenges do hospitals face when joining the personalized nutrition market?

Most consumer platforms export PDF reports rather than structured data compatible with electronic health records. Clinics also need dietitian time for interpretation, which is rarely reimbursed outside defined medical nutrition therapy [3]. Read More

How is the GLP-1 drug wave changing product formulation priorities?

Formulators are raising protein density and adding fiber and micronutrients to offset reduced intake and lean-mass loss. Portion-controlled, high-protein formats now take shelf space once held by general meal replacements [8]. Read More

Which emerging use case could open new revenue streams in the personalized nutrition market?

Healthy-ageing programs for adults over 60, pairing muscle-health biomarkers with protein and vitamin D tailoring, remain underpenetrated. Ageing demographics in Japan and South Korea make this cohort a strong subscription opportunity in the personalized nutrition market [17]. Read More

Personalized Nutrition Market (2026 - 2035)

ID: MRFR/FnB/24046-HCR 128 Pages Varsha More Last Updated: October 13, 2026

Personalized Nutrition Market Size, Share, Industry Trend & Analysis Research Report By Product Type (Active Measurement, Standard Measurement), By Application (Standard Supplements, Disease-based Formulations), By End User (Direct-to-Consumer, Wellness & Fitness Centres, Hospitals & Clinics), By Region (North America, Europe, Asia Pacific, Middle East & Africa, South America) - Forecast to 2035

Personalized Nutrition Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)13.2%

2025 Market SizeUSD 15.35 Billion

2035 Market SizeUSD 53.47 Billion

Key Players

Nestlé Health Science

dsm-firmenich

Herbalife Ltd.

Amway Corp.

Viome Life Sciences

ZOE Ltd.

Trends

OTC Biosensors and At-Home Biomarker Testing
Rising Cardiometabolic Disease Burden
AI-Driven Recommendation Engines

Opportunities

Emerging Asian Markets Under New Regulatory Frameworks
Data Licensing and Platform Business Models
GLP-1 Companion Nutrition Programs

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Summary | |
2 Key Report Takeaways | |
1. 2.1 By Product Type | |
2. 2.2 By Application | |
3. 2.3 By End User | |
4. 2.4 By Region | |
3 Market Size and Forecast (2021–2035) | |
1. 3.1 Historical Market Size (2021–2024) | |
2. 3.2 Base Year and Forecast Market Size (2025–2035) | |
3. 3.3 Year-over-Year Growth Analysis | |
4 Driver Impact Analysis | |
1. 4.1 OTC Biosensors and At-Home Biomarker Testing | |
2. 4.2 Rising Cardiometabolic Disease Burden | |
3. 4.3 AI-Driven Recommendation Engines | |
4. 4.4 GLP-1 Therapy Adoption and Companion Nutrition | |
5. 4.5 Public Research Funding for Nutrition Science | |
6. 4.6 Expanding Regulatory Acceptance of Health Claims | |
5 Restraints Impact Analysis | |
1. 5.1 High Out-of-Pocket Cost and Limited Reimbursement | |
2. 5.2 Genetic and Health-Data Privacy Concerns | |
3. 5.3 Uneven Scientific Validation | |
4. 5.4 Fragmented Health-Claim Regulation | |
5. 5.5 Subscription Churn and Adherence Fatigue | |
6 Opportunities | |
1. 6.1 Emerging Asian Markets Under New Regulatory Frameworks | |
2. 6.2 Data Licensing and Platform Business Models | |
3. 6.3 GLP-1 Companion Nutrition Programs | |
4. 6.4 Food-as-Medicine and Employer Wellness Contracts | |
5. 6.5 Gulf Health-Transformation Programs | |
7 Regional Market Share and Country-Level Analysis | |
1. 7.1 North America | | |
  1. 7.1.1 United States | | |
  2. 7.1.2 Canada | | |
  3. 7.1.3 Mexico | |
2. 7.2 Europe | | |
  1. 7.2.1 Germany | | |
  2. 7.2.2 United Kingdom | | |
  3. 7.2.3 France | | |
  4. 7.2.4 Italy | | |
  5. 7.2.5 Spain | | |
  6. 7.2.6 Rest of Europe | |
3. 7.3 Asia Pacific | | |
  1. 7.3.1 China | | |
  2. 7.3.2 Japan | | |
  3. 7.3.3 India | | |
  4. 7.3.4 South Korea | | |
  5. 7.3.5 Australia | | |
  6. 7.3.6 Rest of Asia Pacific | |
4. 7.4 Middle East & Africa | | |
  1. 7.4.1 GCC | | |
  2. 7.4.2 South Africa | | |
  3. 7.4.3 Rest of Middle East & Africa | |
5. 7.5 South America | | |
  1. 7.5.1 Brazil | | |
  2. 7.5.2 Argentina | | |
  3. 7.5.3 Rest of South America | |
8 Future Outlook (2026–2035) | |
1. 8.1 AI Moves From Recommendation to Continuous Adjustment | |
2. 8.2 Food-as-Medicine Enters Reimbursement Pathways | |
3. 8.3 Falling Cost of Multi-Omics Testing | |
4. 8.4 Data Governance Becomes a Competitive Moat | |
9 Segmentation Analysis | |
1. 9.1 By Product Type | | |
  1. 9.1.1 Active Measurement | | |
  2. 9.1.2 Standard Measurement | |
2. 9.2 By Application | | |
  1. 9.2.1 Standard Supplements | | |
  2. 9.2.2 Disease-based Formulations | |
3. 9.3 By End User | | |
  1. 9.3.1 Direct-to-Consumer | | |
  2. 9.3.2 Wellness & Fitness Centres | | |
  3. 9.3.3 Hospitals & Clinics | |
10 Competitive Landscape | |
1. 10.1 Market Concentration Analysis | |
2. 10.2 Competitive Benchmarking Matrix | |
3. 10.3 Company Profiles | | |
  1. 10.3.1 Nestlé Health Science | | |
  2. 10.3.2 dsm-firmenich | | |
  3. 10.3.3 Herbalife Ltd. | | |
  4. 10.3.4 Amway Corp. | | |
  5. 10.3.5 Viome Life Sciences | | |
  6. 10.3.6 ZOE Ltd. | | |
  7. 10.3.7 InsideTracker | | |
  8. 10.3.8 Bioniq | | |
  9. 10.3.9 Nourished | | |
  10. 10.3.10 GenoPalate | |
11 Recent News & Developments | |
12 Report Scope and Methodology | |
13 Detailed Sources and Citations | |
14 Frequently Asked Questions (FAQs) | | LIST OF TABLES | |
TABLE 1 Global Market Size & Forecast, by Revenue (USD Billion), 2021–2035 | |
TABLE 2 Driver Impact Analysis, 2026–2035 | |
TABLE 3 Restraints Impact Analysis, 2026–2035 | |
TABLE 4 Regional Summary, 2025 | |
TABLE 5 North America — Country-Level Analysis, 2021–2035 (USD Billion) | |
TABLE 6 Europe — Country-Level Analysis, 2021–2035 (USD Billion) | |
TABLE 7 Asia Pacific — Country-Level Analysis, 2021–2035 (USD Billion) | |
TABLE 8 Middle East & Africa — Country-Level Analysis, 2021–2035 (USD Billion) | |
TABLE 9 South America — Country-Level Analysis, 2021–2035 (USD Billion) | |
TABLE 10 Global Market Size, by Product Type, 2021–2035 (USD Billion) | |
TABLE 11 Global Market Size, by Application, 2021–2035 (USD Billion) | |
TABLE 12 Global Market Size, by End User, 2021–2035 (USD Billion) | |
TABLE 13 North America Market Size, by Product Type, 2021–2035 (USD Billion) | |
TABLE 14 North America Market Size, by Application, 2021–2035 (USD Billion) | |
TABLE 15 North America Market Size, by End User, 2021–2035 (USD Billion) | |
TABLE 16 Europe Market Size, by Product Type, 2021–2035 (USD Billion) | |
TABLE 17 Europe Market Size, by Application, 2021–2035 (USD Billion) | |
TABLE 18 Europe Market Size, by End User, 2021–2035 (USD Billion) | |
TABLE 19 Asia Pacific Market Size, by Product Type, 2021–2035 (USD Billion) | |
TABLE 20 Asia Pacific Market Size, by Application, 2021–2035 (USD Billion) | |
TABLE 21 Asia Pacific Market Size, by End User, 2021–2035 (USD Billion) | |
TABLE 22 Middle East & Africa Market Size, by Product Type, 2021–2035 (USD Billion) | |
TABLE 23 Middle East & Africa Market Size, by Application, 2021–2035 (USD Billion) | |
TABLE 24 Middle East & Africa Market Size, by End User, 2021–2035 (USD Billion) | |
TABLE 25 South America Market Size, by Product Type, 2021–2035 (USD Billion) | |
TABLE 26 South America Market Size, by Application, 2021–2035 (USD Billion) | |
TABLE 27 South America Market Size, by End User, 2021–2035 (USD Billion) | |
TABLE 28 Competitive Benchmarking Matrix, 2025 | |
TABLE 29 Recent News & Developments, 2023–2025 | |
TABLE 30 Report Scope and Methodology | |
TABLE 31 Detailed Sources and Citations | |
TABLE 32 Segmentation Quick Reference | | LIST OF FIGURES | |
FIGURE 1 Market Dynamics Overview — Drivers, Restraints, Opportunities | |
FIGURE 2 Industry Value Chain Analysis | |
FIGURE 3 Porter's Five Forces Analysis | |
FIGURE 4 Global Market Size Trend, 2021–2035 (USD Billion) | |
FIGURE 5 Year-over-Year Growth Rate, 2022–2035 | |
FIGURE 6 Market Share by Product Type, 2025 | |
FIGURE 7 Market Share by Application, 2025 | |
FIGURE 8 Market Share by End User, 2025 | |
FIGURE 9 Regional Market Share, 2025 | |
FIGURE 10 Regional CAGR Comparison, 2026–2035 | |
FIGURE 11 North America Country Share, 2025 | |
FIGURE 12 Europe Country Share, 2025 | |
FIGURE 13 Asia Pacific Country Share, 2025 | |
FIGURE 14 Competitive Landscape — Estimated Revenue Share Ranges of Key Players, 2025 | |
FIGURE 15 Competitive Positioning Matrix

Certified Researchers

Enquiry

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product Type	Active Measurement; Standard Measurement	Active Measurement (largest revenue share)	Active Measurement (14.3% CAGR (2026–2035))
By Application	Standard Supplements; Disease-based Formulations	Standard Supplements (53.0% share (2025))	Disease-based Formulations (13.8% CAGR (2026–2035))
By End User	Direct-to-Consumer; Wellness & Fitness Centres; Hospitals & Clinics	Direct-to-Consumer (59.1% share (2025))	Wellness & Fitness Centres (13.4% CAGR (2026–2035))
By Region	North America; Europe; Asia Pacific; Middle East & Africa; South America	North America (38.6% share (2025))	Asia Pacific (15.6% CAGR (2026–2035))

Market Segmentation Overview

By Product Type

Sub-Segment	Key Trend
Active Measurement	OTC glucose biosensors and at-home blood panels enable monthly reformulation
Standard Measurement	Questionnaire-based packs move into pharmacy and grocery retail

Active Measurement leads revenue and posts the fastest growth because biosensor and blood-panel data let providers demonstrate measurable outcomes, which supports premium subscription pricing. Standard Measurement keeps a 46.0% share among cost-conscious buyers, but its growth trails as consumers favor offerings that track results. Hybrid models that add optional testing to low-cost baseline packs give Standard Measurement providers a path to defend share.

By Application

Sub-Segment	Key Trend
Standard Supplements	Daily packs for energy, immunity, and cognition remain the entry point
Disease-based Formulations	Clinician-referred regimens for prediabetes, obesity, and cardiovascular risk

Standard Supplements lead with a 53.0% share because they require no clinical involvement and suit first-time buyers. Disease-based Formulations grow faster at a 13.8% CAGR as qualified health claims and clinician referrals legitimize nutrition as therapy for metabolic conditions. Their higher evidence burden is offset by premium pricing and longer patient retention.

By End User

Sub-Segment	Key Trend
Direct-to-Consumer	Subscription models with remote sampling and app-based coaching
Wellness & Fitness Centres	Gyms bundle biomarker testing with training and recovery plans
Hospitals & Clinics	Multidisciplinary nutrition oversight in bariatric and oncology care

Direct-to-Consumer dominates with a 59.1% share because doorstep kits and app coaching remove clinical gatekeepers. Wellness & Fitness Centres grow fastest at a 13.4% CAGR, since in-person guidance raises adherence among performance-focused members. Hospitals & Clinics hold a smaller but stable position where nutrition must be coordinated with complex medical treatment.

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”